Procurement
Expert Panel
Create New Account
Login
logo
Report store
Insights
Survey
Consulting
Book discovery call
logo

Neuromodulation Devices Market: Current Analysis and Forecast (2021-2027)

Region:Global

Product Code:UMHE21246

Download Sample Report
Published On

June 2021

Total pages

184

About the Report

ACCORDING TO THE INSTITUTE OF MEDICINE (US), 100 MILLION AMERICAN ADULTS ARE AFFECTED BY CHRONIC PAIN, HIGHER THAN THE COMBINED TOTAL NUMBER OF PEOPLE EFFECTED BY CANCER, DIABETES, AND HEART DISEASE. PAIN CAN AFFECT IN ONE'S BODY FUNCTIONING EVEN WHILE PERFORMING THE SIMPLEST ACTIVITIES. NEUROMODULATION HAS HELPED PATIENTS RECOVER COMPLETELY FROM THESE CHRONIC PAINS AND RESUME THEIR ROUTINE LIVES. THERE ARE MULTIPLE TYPES OF NEUROMODULATIONS THAT CAN BE USED SUCH AS SPINAL DRUG DELIVERY SYSTEMS, SPINAL CORD STIMULATION, BRAIN STIMULATION, SACRAL STIMULATION, PERIPHERAL NERVE STIMULATION AND PERIPHERAL NERVE FIELD STIMULATION. MANY RESEARCH AND CLINICAL TRIALS HAVE PUBLISHED PROMISING PAPERS PROVING THE ABILITY AND SAFETY OF NEUROMODULATION DEVICES TO IMPROVE QUALITY OF LIFE OF PATIENTS. THE NERVOUS SYSTEM'S ELECTRICAL PROPERTIES WERE DISCOVERED MORE THAN A HUNDRED YEARS AGO, HOWEVER, THEY HAVE ONLY BEEN HARNESSED FOR TREATMENTS RECENTLY. FIRST COCHLEAR IMPLANTS, ENHANCING PATIENTS' AWARENESS OF THE ENVIRONMENT AND AID THEM WITH LIP READING WERE INVENTED IN 1970S.

BASED ON TECHNOLOGY THE NEUROMODULATION DEVICES MARKET IS DIVIDED INTO SPINAL CORD STIMULATORS, DEEP BRAIN STIMULATORS, SACRAL NERVE STIMULATORS, VAGUS NERVE STIMULATORS, TRANSCRANIAL MAGNETIC STIMULATORS, AND OTHERS. SPINAL CORD STIMULATORS SEGMENT IS EXPECTED TO WITNESS HIGHEST CAGR GROWTH DURING THE FORECAST PERIOD. NEUROMODULATION DEVICES HAVE GROWN AT THEIR HIGHEST IN THE LAST DECADE, WITH NOVEL CHRONIC PAIN INDICATIONS, HARDWARE ADVANCEMENTS AND WAVEFORMS. IN 2021, MEDTRONIC ANNOUNCED THE FDA HAS APPROVED ITS RECHARGE-FREE NEUROSTIMULATOR FOR SPINAL CORD STIMULATION, VANTA. IN THE SAME YEAR, CVRX FILED PAPERWORK TO HOLD AN IOP TO RAISE UP TO USD 75 MILLION TO COMMERCIALIZE ITS NEUROSTIMULATOR FOR HEART FAILURE. SPINAL CORD STIMULATION (SCS) IS USED IN MANY REFRACTORY CHRONIC PAIN CONDITIONS LIKE COMPLEX REGIONAL PAIN SYNDROME, FAILED BACK SURGERY SYNDROME, ANGINA PECTORIS, ABDOMINAL PAIN, AND ISCHEMIC LIMB PAIN.

BASED ON APPLICATION, NEUROMODULATION DEVICES MARKET IS SEGMENTED INTO PAIN MANAGEMENT, HEARING LOSS, DEPRESSION, PARKINSON'S DISEASE, EPILEPSY, AND OTHERS. PAIN MANAGEMENT IS EXPECTED TO WITNESS HIGHEST CAGR GROWTH DURING THE FORECAST PERIOD. NEUROMODULATION TOOLS CAN INCREASE OR DECREASE THE ACTIVITY IN THE NERVOUS SYSTEM. THIS TECHNOLOGY CAN BE EFFECTIVE IN REDUCING MANY NERVOUS SYSTEM RELATED DISEASES, PAIN, HEARING, EPILEPSY ETC. ACCORDING TO WHO, THERE ARE CURRENTLY 264 MILLION PEOPLE SUFFERING FROM DEPRESSION IN 2020 AND 50 MILLION PEOPLE SUFFERING FROM EPILEPSY (2019) WORLDWIDE. ADDITIONALLY, THE NATIONAL INSTITUTES OF HEALTH IN 2020 PUBLISHED THAT, 1 IN 5 PEOPLE IN THE UNITED STATES SUFFER FROM CHRONIC PAIN. RECENT ADVANCEMENTS IN COCHLEAR IMPLANTS HAVE ENABLED PEOPLE TO HEAR AND UNDERSTAND SPEECH. COCHLEAR IMPLANTS SAVE USD 30,000-50,000 PER PERSON OVER THEIR LIFETIMES. MORE THAN 100,000 PARKINSON'S PATIENTS HAVE BEEN IMPLANTED WITH DEEP BRAIN STIMULATION (DBS). THIS IS BETTER THAN DRUG THERAPY, WHICH CAUSES UNPLEASANT SIDE-EFFECTS. DBS CAN REDUCE THE PATIENT'S RELIANCE ON DRUGS AND LESSEN THEIR SIDE EFFECTS BY UP TO 44%.

FOR A BETTER UNDERSTANDING OF THE MARKET AND THE DEVICE ADOPTION, THE REPORT PROVIDES DETAILED ANALYSIS FOR MAJOR REGIONS INCLUDING NORTH AMERICA (US, CANADA, AND REST OF NORTH AMERICA), EUROPE (GERMANY, FRANCE, ITALY, SPAIN, UK AND REST OF EUROPE), ASIA-PACIFIC (CHINA, JAPAN, INDIA, AUSTRALIA, AND REST OF APAC), AND REST OF WORLD. NORTH AMERICA CONSTITUTES A MAJOR MARKET FOR THE NEUROMODULATION DEVICES INDUSTRY AND GENERATED REVENUE OF USD XX BILLION IN 2020 OWING TO THE INCREASING INCIDENCE OF NEUROLOGICAL DISEASES. SOME OF THE MAJOR PLAYERS OPERATING IN THE MARKET INCLUDE ABBOTT LABORATORIES, BOSTON SCIENTIFIC CORPORATION, MEDTRONIC PLC, NEVRO CORPORATION, ST. JUDE MEDICAL, INC., NEUROSIGMA INC., NEURONETICS INC., LIVANOVA PLC, NUVECTRA, CYBERONICS. SEVERAL M&A'S ALONG WITH PARTNERSHIPS HAVE BEEN UNDERTAKEN BY THESE PLAYERS TO DEVELOP NEUROMODULATION DEVICES.

Scope of the Report

Products

According to the Institute of Medicine (US), 100 million American adults are affected by chronic pain, higher than the combined total number of people effected by cancer, diabetes, and heart disease.

Companies

ABBOTT LABORATORIES

BOSTON SCIENTIFIC CORPORATION

MEDTRONIC PLC

NEVRO CORPORATION

ST. JUDE MEDICAL

INC.

NEUROSIGMA INC.

NEURONETICS INC.

LIVANOVA PLC

NUVECTRA

CYBERONICS

Table of Contents

1 MARKET INTRODUCTION

1.1 MARKET DEFINITIONS

1.2 OBJECTIVE OF THE STUDY

1.3 LIMITATION

1.4 STAKE HOLDERS

1.5 CURRENCY USED IN REPORT

1.6 SCOPE OF THE NEUROMODULATION DEVICES MARKET STUDY

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 RESEARCH METHODOLOGY FOR THE NEUROMODULATION DEVICES MARKET

2.1.1 MAIN OBJECTIVE OF THE NEUROMODULATION DEVICES MARKET

3 INDUSTRY PERFORMANCE

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 MARKET INSIGHTS BY TECHNOLOGY

6.1 SPINAL CORD STIMULATORS

6.2 DEEP BRAIN STIMULATORS

6.3 SACRAL NERVE STIMULATORS

6.4 VAGUS NERVE STIMULATORS

6.5 TRANSCRANIAL MAGNETIC STIMULATORS

6.6 OTHERS

7 MARKET INSIGHTS BY APPLICATION

7.1 PAIN MANAGEMENT

7.2 HEARING LOSS

7.3 DEPRESSION

7.4 PARKINSON'S DISEASE

7.5 EPILEPSY

7.6 OTHERS

8 MARKET INSIGHTS BY REGION

8.1 NORTH AMERICA NEUROMODULATION DEVICES MARKET

8.1.1 UNITED STATES OF AMERICA

8.1.2 CANADA

8.1.3 REST OF NORTH AMERICA

8.2 EUROPE NEUROMODULATION DEVICES MARKET

8.2.1 UNITED KINGDOM

8.2.2 GERMANY

8.2.3 FRANCE

8.2.4 SPAIN

8.2.5 ITALY

8.2.6 REST OF EUROPE

8.3 ASIA-PACIFIC NEUROMODULATION DEVICES MARKET

8.3.1 CHINA

8.3.2 JAPAN

8.3.3 INDIA

8.3.4 AUSTRALIA

8.3.5 REST OF ASIA-PACIFIC

8.4 REST OF THE WORLD NEUROMODULATION DEVICES MARKET

9 LEGAL AND REGULATORY FRAMEWORK

10 DEMAND AND SUPPLY SIDE ANALYSIS

10.1 DEMAND SIDE ANALYSIS

10.2 SUPPLY SIDE ANALYSIS

10.2.1 TOP PRODUCT LAUNCHES

10.2.2 TOP BUSINESS PARTNERSHIPS

10.2.3 TOP BUSINESS EXPANSIONS, INVESTMENTS AND DIVESTITURES

10.2.4 TOP MERGER AND ACQUISITIONS

11 VALUE CHAIN ANALYSIS

12 NEUROMODULATION DEVICES MARKET TRENDS & INSIGHTS

13 NEUROMODULATION DEVICES MARKET DYNAMICS

13.1 DRIVERS

13.2 CHALLENGES

13.3 IMPACT ANALYSIS

13.4 OPPORTUNITY

14 COMPETITIVE SCENARIO

14.1 NEUROMODULATION DEVICES MARKET SHARE, BY COMPANY 2020

15 COMPANY PROFILED

15.1 ABBOTT LABORATORIES

15.2 BOSTON SCIENTIFIC CORPORATION

15.3 MEDTRONIC PLC

15.4 NEVRO CORPORATION

15.5 ST. JUDE MEDICAL, INC.

15.6 NEUROSIGMA INC.

15.7 NEURONETICS INC.

15.8 LIVANOVA PLC

15.9 NUVECTRA

15.10 CYBERONICS

16 DISCLAIMER

Research Methodology

Why Buy From Us?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022